Queen Mary Hospital
Hong Kong, China
Location status: Recruiting
Location contact
Brian SH Ho, MBBS
CONTACT
Sau Loi Ng, BN, DN
CONTACT
NCT Number: NCT06037356
The study will be a prospective, randomized controlled trial comparing prostatic urethral lift (PUL) versus transurethral resection of prostate (TURP) in benign prostate hyperplasia (BPH) patients with urinary retention. The primary objective of this study is to compare the catheter-free rates of PUL vs TURP. Secondary objectives include comparison of complications rates, cost effectiveness, patient satisfactory, symptom scores, quality of life measures and urodynamic parameters.
Interested in participating?
Request Info40 year and older
Male
Interventional
Not applicable
Hong Kong, China
Location status: Recruiting
Brian SH Ho, MBBS
CONTACT
Sau Loi Ng, BN, DN
CONTACT
The study will be a prospective, non-inferiority randomized controlled trial with the aim of detecting a non-inferiority margin of 5%.
After the potential subject has been informed of the study and the potential risks, he will be screened for eligibility within a 4 week period. Assessment of eligibility will include questionnaires, blood tests, urine tests, uroflowmetry, flexible cystoscopy, transrectal ultrasound, and urodynamic study. Suitable subjects will then be randomized in a 1:1 ratio to the prostatic urethral lift (intervention group) and TURP (control group). Patients in the prostatic urethral lift will have the procedure performed under local anesthesia or monitored anesthetic care while TURP patients will be performed under spinal or general anesthesia. The subjects will have regular follow up 1 month, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, and 5 years post-operatively. Follow up assessments will include questionnaires, uroflowmetry, and occasional urodynamic study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Prostatic urethral lift uses permanent implants to retract the prostate lobes away from the prostate urethra to allow unobstructed passage of urine. These implants are made of Nitinol, non-absorbable monofilament suture material (Poly Ethylene Terephthalate), Stainless Steel
Other names: PUL, Urolift
Using monopolar or bipolar loop diathermy via cystoscopy, excess prostate tissue is resected piecemeal to remove obstruction to the prostatic urethra due to BPH
Other names: Transurethral resection of prostate
Time frame: 1 year after intervention
To determine how many patients will be catheter-free (defined as by the ability to void with a post-void residual urine <300mL) after intervention and remain catheter-free at 1 month, 3 months, and 1 year after intervention
Time frame: 5 years
To determine the percentage and severity of complications after each intervention (according to the Clavien-Dindo classification)
Time frame: 1 year
To determine the cost required to achieve catheter free patients for each intervention (including hospitalization, anesthetic costs, equipment, consumables, etc)
Time frame: 1 year
Using the Patient global impression of improvement (PGI-I) questionnaire to determine patient satisfaction after each intervention.
Time frame: 1 year
Using International prostate symptom score (IPSS) questionnaire to determine patient reported symptom measure after each intervention
Time frame: 1 year
Using the Incontinence severity index (ISI) questionnaire to determine patient reported symptom measure after each intervention
Time frame: 1 year
Using the International index of erectile function- 5 items (IIEF-5) questionnaire to determine patient reported symptom measure after each intervention
Time frame: 1 year
Using the Male Sexual Health Questionnaire for Ejaculatory Dysfunction (MSHQ-EjD) short form questionnaire to determine patient reported symptom measure after each intervention.
Time frame: 1 year
Using the Short Form 12 (SF-12) questionnaire to determine patient reported quality of life measures after each intervention
Time frame: 1 year
Using the derived Short Form 6 Dimension (SF-6D) utility score questionnaire to determine patient reported quality of life measures after each intervention
Time frame: 1 year
Using the Visual analogue scale of quality of recovery to determine patient reported recovery after each intervention
Time frame: 5 year
Pre- and post-intervention urodynamic will be performed to assess bladder contractility index as well as subsequent improvement and durability of above stated urodynamic parameter after each intervention
Time frame: 5 year
Pre- and post-intervention urodynamic will be performed to assess bladder outflow obstruction index (BOOI) as well as subsequent improvement and durability of above stated urodynamic parameter after each intervention
Contact information is provided by the study sponsor or research team.
Brian SH Ho, MBBS
CONTACT
Stacia Chun, BSc(Hons)
CONTACT
Queen Mary Hospital, Hong Kong
Other
Prostatic Urethral Lift Versus Transurethral Resection of Prostate in Benign Prostatic Hyperplasia Patients With Urinary Retention
Acronym: PULTUR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07209150
Antibiotic Prophylaxis, BPH With Urinary Obstruction
View Trial DetailsNCT05652023
BPH With Urinary Obstruction, Bladder Dysfunction
Rochester, Minnesota, United States
View Trial DetailsNCT07187180
BPH With Symptomatic Lower Urinary Tract Symptoms, BPH With Urinary Obstruction
Cleveland, Ohio, United States
View Trial DetailsNCT05620784
BPH, BPH With Urinary Obstruction
Chicago, Illinois, United States
View Trial Details